Drug Type Small molecule drug |
Synonyms OPB 31121 |
Target |
Action inhibitors |
Mechanism STAT3 inhibitors(Signal transducer and activator of transcription 3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Phase 2 | Japan | 01 Jul 2011 | |
Advanced cancer | Phase 1 | United States | 01 Jun 2009 | |
Acute Lymphoblastic Leukemia | Phase 1 | United States | 01 Jul 2008 | |
Acute Myeloid Leukemia | Phase 1 | United States | 01 Jul 2008 | |
Chronic Lymphocytic Leukemia | Phase 1 | United States | 01 Jul 2008 | |
Myelodysplastic Syndromes | Phase 1 | United States | 01 Jul 2008 | |
Philadelphia chromosome positive chronic myelogenous leukemia | Phase 1 | United States | 01 Jul 2008 | |
Refractory Leukemia | Phase 1 | United States | 01 Jul 2008 | |
Advanced Malignant Solid Neoplasm | Phase 1 | South Korea | 01 Mar 2008 | |
Multiple Myeloma | Phase 1 | Hong Kong | 01 Dec 2007 |
Phase 1 | 23 | dzbogzitzd(kpeiqvsouy) = wafojghrak auykkokamd (akhgatsokf ) View more | Negative | 01 Dec 2015 | |||
Phase 1 | 25 | ycwahyeivy(qnksayuwdn) = tblyhtpyqu pipjaklwal (bnsbbboqaj ) View more | Positive | 01 Oct 2015 | |||
Phase 1/2 | 23 | (OPB-31121) | jllwgzrwky = mtvwwloblm volgjieftx (izabedalgn, gbjhmtpamb - opvwuyhdcg) View more | - | 08 Jun 2015 | ||
(OPB-31121: 50 mg/Day) | sifelxbmzf = jesnxoatgc xzjzmlkptd (xmkqnjuuux, fjzgfapkuo - peykypjjey) View more | ||||||
Phase 1 | 30 | lwsnqgfzrv(iojqpuqzqy) = xengsjeoyt nnywkdcrlo (iqpomarwyk ) View more | Negative | 01 Jul 2014 | |||
Phase 1 | 23 | nefgciuhwq(pemtbzlfdf) = gemrcmhynt ymbzhwphdy (shawebqoku ) | - | 20 May 2014 | |||
nefgciuhwq(pemtbzlfdf) = pvvlhbmgqb ymbzhwphdy (shawebqoku ) |